SURVANTA INTRATRACHEAL 4ML VIAL
BERACTANT
Availability: Out of stock
Old price: 2٬830٫000 (EGP)
1٬415٫000 (EGP)
1. Treatment for respiratory distress syndrome in premature infants. 2. Improves lung function. 3. Reduces the risk of respiratory complications. 4. Surfactant replacement therapy. 5. Used in neonatal intensive care for respiratory support.